Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Concord Biotech Ltd. Share Price
Day's Range
Day's Range
Low
₹1,246.40
High
₹1,267.00
Price Summary
| Previous Close | ₹1,252.10 |
|---|---|
| Day's Range | ₹1,246.40 - ₹1,267.00 |
| Open | ₹1,267.00 |
| 52 Week Range | ₹987.00 - ₹1,905.00 |
| Volume | 12,459 |
| Market Cap | ₹0.01 |
| Previous Close | ₹1,254.70 |
|---|---|
| Day's Range | ₹1,246.60 - ₹1,263.50 |
| Open | ₹1,256.05 |
| 52 Week Range | ₹987.05 - ₹1,905.65 |
| Volume | 1,625 |
| Market Cap | ₹0.01 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 156.00 |
|---|---|
| Market Cap (₹ in Mn) | 0.01 |
| Dividend Yield(%) | 0.60 |
| Price/Earning (TTM) | 50.40 |
| TTM EPS (₹) | 24.94 |
| P/E Ratio | 40.73 |
| Book Value(₹) | 6.52 |
| PAT Margin (%) | 24.57 |
| Face Value (₹) | 1.00 |
| ROCE(%) | 18.04 |
| Trade Value ( ₹ in Lacs) | 20.39 |
|---|---|
| Market Cap (₹ in Mn) | 0.01 |
| Dividend Yield(%) | 0.60 |
| Price/Earning (TTM) | 50.40 |
| TTM EPS (₹) | 24.94 |
| P/E Ratio | 40.73 |
| Book Value(₹) | 6.52 |
| PAT Margin (%) | 24.57 |
| Face Value (₹) | 1.00 |
| ROCE(%) | 18.04 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 12000.87 | 4298.84 |
| Expenses | N/A | N/A |
| PBT | 4958.76 | 1835.45 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 3729.64 | 1403.87 |
About Concord Biotech Ltd.
| Founded | 1984 |
|---|---|
| Managing Director | Sudhir Vaid |
| NSE Symbol | CONCORDBIO |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,73,508.76 | 1,983.90 | 1,548.00 - 1,548.00 |
| Divi's Laboratories Ltd. | 1,96,880.79 | 7,395.05 | 5,636.50 - 5,636.50 |
| Torrent Pharmaceuticals Ltd. | 1,90,832.46 | 4,893.30 | 3,480.60 - 3,480.60 |
| Apollo Hospitals Enterprise Ltd. | 1,27,148.77 | 8,865.00 | 6,696.50 - 6,696.50 |
| Cipla Ltd. | 1,13,894.07 | 1,435.70 | 1,165.70 - 1,165.70 |
| Zydus Lifesciences Ltd. | 1,10,523.42 | 1,101.00 | 835.50 - 835.50 |
| Lupin Ltd. | 1,10,189.04 | 2,395.35 | 1,836.80 - 1,836.80 |
| Max Healthcare Institute Ltd. | 1,08,476.19 | 1,104.00 | 903.00 - 903.00 |
| Mankind Pharma Ltd. | 1,05,357.34 | 2,600.90 | 1,909.70 - 1,909.70 |
| Lenskart Solutions Ltd. | 99,446.13 | 560.20 | 0.00 - 0.00 |
No Records Found
Latest News
Concord Biotech informs about newspaper publication
Concord Biotech informs about updates
Concord Biotech informs about press release
Concord Biotech informs about board meeting
Concord Biotech has informed that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026, inter alia, to consider and approve the audited Standalone and Consolidated Financial Results for the fourth quarter and financial year ended March 31, 2026 along with audit report thereon and subject to approval of shareholders at the ensuing Annual General Meeting, to recommend final dividend on equity shares of the Company.
The above information is a part of company’s filings submitted to BSE.
Ipca Laboratories informs about board meeting
Pursuant to Regulation 29 read with Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Ipca Laboratories has informed that a meeting of the Board of Directors of the Company will be held on Thursday, 13th August, 2026, to consider and take on record the standalone and consolidated unaudited financial results of the Company for the 1st quarter ended 30th June, 2026 of the financial year 2026-27. Further, with reference to the above meeting of the Board of Directors, it has already informed vide its letter dated 22nd June, 2026 that the trading window for dealing in the securities of the Company by the Insiders as defined under the SEBI (Prohibition of Insider Trading) Regulations, 2015 shall remain closed with effect from 1st July, 2026 and until 48 hours after the declaration of the Company’s unaudited financial results for the 1st quarter ended 30th June, 2026 i.e., till 15th August, 2026.
The above information is a part of company’s filings submitted to BSE.
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Concord Biotech Ltd. is ₹1,252.10 as of 2026-07-28.
The market capitalisation of Concord Biotech Ltd. is ₹13,150.26 as of 2026-07-27.
The 1-year return of Concord Biotech Ltd. is -628.70% as of 2026-07-28.
The P/E ratio of Concord Biotech Ltd. is 40.73 as of 2026-07-28.
The 52-week high and low of Concord Biotech Ltd. are ₹1,905.00 and ₹987.00, respectively, as of 2026-07-28.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
